Vnitr Lek 2009, 55(7-8):666-669

Laboratory markers of metabolic syndrome in clinical practice

V. Soška1,2
1 Oddělení klinické biochemie FN u sv. Anny Brno, přednosta doc. MUDr. Vladimír Soška, CSc.
2 II. interní klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MUDr. Miroslav Souček, CSc.

The incidence of metabolic syndrome is evidenced by the presence of three out of five criteria:
larger waistline, elevated blood pressure, raised triglyceride levels, reduced HDL-cholesterol and raised fasting glycaemia (or diabetes mellitus). Laboratory picture of metabolic syndrome also includes presence of small LDL3 particles and increased concentration of apolipoprotein B. Determination of glycaemia and triglycerides and HDL-cholesterol levels is fundamental for the diagnosis of metabolic syndrome. The risk of the so-called "pre-analytical" error has to be minimized in order for the results of these investigations to be sufficiently reliable, i.e. the recommendations related to the preparation of the patient, blood sampling itself and the transportation of the sample to a laboratory has to be adhered to. If the laboratory results fall into the borderline (critical) values, it is appropriate to repeat blood sampling.

Keywords: metabolic syndrome; glycaemia; triglycerides; HDL-cholesterol; apolipoprotein B; pre-analytical error

Received: March 29, 2009; Published: July 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soška V. Laboratory markers of metabolic syndrome in clinical practice. Vnitr Lek. 2009;55(7-8):666-669.
Download citation

References

  1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. Go to original source... Go to PubMed...
  2. Barter PJ, Ballantyne CM, Carmena R et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten country panel. J Intern Med 2006; 259: 247-258. Go to original source... Go to PubMed...
  3. Horák P. Metodická úskalí stanovení LDL cholesterolu. Labor Aktuell (CS) 2001; 2: 8-12.
  4. Vaverková H, Soška V, Rosolová H et al. Doporučení pro diagnostiku a léčbu dyslipidemií v dospělosti, vypracované výborem České společnosti pro aterosklerózu. Vnitř Lék 2007; 53: 181-197. Go to PubMed...
  5. Cífková R, Býma S, Češka R et al. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností. Vnitř Lék 2005; 51: 1021-1036.
  6. Sacks FM. Expert Group on HDL cholesterol. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am J Cardiol 2002: 90: 139-142. Go to original source... Go to PubMed...
  7. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster Study. Am J Cardiol 1992; 70: 733-737. Go to original source... Go to PubMed...
  8. Gallin JI, Kaye D, O'Leary WM. Serum lipids in infection. N Engl J Med 1969; 281: 1081-1086. Go to original source... Go to PubMed...
  9. Crouse JR, Grundy SM. Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J Lipid Res 1984; 25: 486-496. Go to original source...
  10. Baraona E, Lieber CS. Alcohol. In: Betteridge DJ, Illingworth DR (eds). Lipoproteins in health and disease. London: Arnold 1999: 1011-1036.
  11. Miller M, Bachorik PS, Cloey TA. Normal variation of plasma lipoproteins: postural effects on plasma concentration of lipids, lipoproteins and apolipoproteins. Clin Chem 1992; 38: 569-574. Go to original source...
  12. Page IH, Moinuddin M. The effect of venous occlusion on serum cholesterol and total protein concentration - a warning. Circulation 1962; 25: 651-652. Go to original source... Go to PubMed...
  13. Friedewald W T, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.